Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Natalia Fendrikova Mahlay, MD, is a staff physician in the Department of Vascular Medicine in the Sydell and Arnold Miller Heart & Vascular Institute.
Dr. Fendrikova Mahlay earned her medical degree from O. Bohomoletz National Medical University in her native country of Ukraine, earning the distinction of Physician Diplomate with Honor. During her residency she participated in international research projects and later was selected to continue her training in the United States as part of a physician exchange program.
Dr. Fendrikova Mahlay graduated from an internal medicine residency program at St. Vincent Charity Hospital, Cleveland. She completed her professional training with a vascular medicine fellowship at Cleveland Clinic and was appointed to the Cleveland Clinic staff in 2011.
She is a member of the American College of Physicians, Society of Vascular Medicine, and the Ukrainian Medical Society. She had been an active member of the Scientific Society of O. Bohomoletz National Medical University. During her training, Dr. Mahlay was honored as Intern of the Year in the internal medicine residency program at St. Vincent Charity Hospital and earned an Honor Diploma from the National Institute of Continuing Medical Education in Ukraine.
Dr. Fendrikova Mahlay served on the Board of Directors of the Ukrainian Museum Archives and volunteers with the Children of Chernobyl Relief Fund. Fluent in Ukrainian and Russian, she also volunteers as an interpreter.
Chronic venous insufficiency, blood clots, deep vein thrombosis, hypercoagulable states, peripheral artery disease, pulmonary embolism, vascular anomalies, venous disorders
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 6/21/2015, Dr. Fendrikova Mahlay has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.